Office of Research & Development |
![]() ![]() |
Project Number: | I01BX003692-01 |
Title: | The Role of EZH2 in Non-Muscle Invasive Bladder Cancer |
Principal Investigator: | Joshua Meeks |
Location: | Chicago, IL |
Congressional District Code: | 7 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2016 - March 2021 |
FY 2021 Funding Amount: | $0 |
Total Award Amount (all years): |
$738,273 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Bladder cancer is the fourth most common cancer in men and a significant burden for Veterans and the VHA due to the high frequency of recurrence and progression linked to smoking and exposure to deployment- related carcinogens. Nearly 80% of bladder cancers do not invade the muscle of the bladder wall (called “non- muscle invasive bladder cancer”, NMIBC) but the most aggressive of these tumors will progress to muscle invasion with lymph node metastasis resulting in death in 30% of patients. The... |